Xact Kapitalforvaltning AB lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 175,331 shares of the healthcare conglomerate’s stock after buying an additional 12,620 shares during the quarter. UnitedHealth Group comprises 1.0% of Xact Kapitalforvaltning AB’s portfolio, making the stock its 14th biggest holding. Xact Kapitalforvaltning AB’s holdings in UnitedHealth Group were worth $32,510,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Catawba Capital Management VA raised its stake in shares of UnitedHealth Group by 12.7% in the second quarter. Catawba Capital Management VA now owns 4,245 shares of the healthcare conglomerate’s stock worth $787,000 after buying an additional 480 shares during the period. Handelsbanken Fonder AB raised its stake in shares of UnitedHealth Group by 34.3% in the second quarter. Handelsbanken Fonder AB now owns 580,300 shares of the healthcare conglomerate’s stock worth $107,599,000 after buying an additional 148,200 shares during the period. First American Trust FSB raised its stake in shares of UnitedHealth Group by 51.7% in the second quarter. First American Trust FSB now owns 24,542 shares of the healthcare conglomerate’s stock worth $4,551,000 after buying an additional 8,359 shares during the period. Independent Portfolio Consultants Inc. raised its stake in shares of UnitedHealth Group by 58.9% in the second quarter. Independent Portfolio Consultants Inc. now owns 1,851 shares of the healthcare conglomerate’s stock worth $343,000 after buying an additional 686 shares during the period. Finally, Hefty Wealth Partners raised its stake in shares of UnitedHealth Group by 11.5% in the second quarter. Hefty Wealth Partners now owns 6,534 shares of the healthcare conglomerate’s stock worth $1,211,000 after buying an additional 672 shares during the period. 86.21% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This piece was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://ledgergazette.com/2017/09/16/xact-kapitalforvaltning-ab-buys-12620-shares-of-unitedhealth-group-incorporated-unh.html.
Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.23% during midday trading on Friday, hitting $198.18. The company’s stock had a trading volume of 4,198,691 shares. UnitedHealth Group Incorporated has a 12-month low of $133.03 and a 12-month high of $200.76. The firm has a 50-day moving average of $195.28 and a 200 day moving average of $180.64. The firm has a market cap of $191.61 billion, a price-to-earnings ratio of 23.81 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same period last year, the business posted $1.96 earnings per share. The company’s quarterly revenue was up 7.7% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be given a dividend of $0.75 per share. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.51%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.
Several research analysts have recently commented on the company. Jefferies Group LLC reaffirmed a “buy” rating and issued a $192.00 price objective on shares of UnitedHealth Group in a research note on Friday, May 19th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $201.00 price objective on the stock in a research note on Wednesday, June 7th. Barclays PLC raised their price objective on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 19th. Cowen and Company reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Friday, July 14th. Finally, Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, June 9th. One analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $203.41.
In related news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the transaction, the director now directly owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 25,600 shares of company stock valued at $4,962,694. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com’s FREE daily email newsletter.